# Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension

> **NCT00822055** · PHASE4 · COMPLETED · sponsor: **Allergan** · enrollment: 140 (actual)

## Conditions studied

- Open-Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** brimonidine tartrate 0.2%/timolol maleate 0.5% fixed combination
- **DRUG:** dorzolamide hcl 2%/timolol maleate 0.5% fixed combination
- **DRUG:** brimonidine tartrate 0.2%/timolol maleate 0.5% fixed combination as adjunctive to current prostaglandin therapy
- **DRUG:** dorzolamide hcl 2%/timolol maleate 0.5% fixed combination as adjunctive to current prostaglandin therapy

## Key facts

- **NCT ID:** NCT00822055
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2006-11
- **Final completion:** 2006-11
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2009-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00822055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00822055, "Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00822055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*